RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2019

Mar 15, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2019-03-13

Reporting Person: Gottesdiener Keith Michael (Director, CEO & President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-13	Common Stock	S	7782	$30.06	Disposed	518138	Direct
2019-03-14	Common Stock	S	1506	$30.05	Disposed	516632	Direct

Footnotes

F1: On March 13, 2019, Mr. Gottesdiener sold 7,782 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.20, inclusive; the price reported above reflects the weighted average sale price. Mr. Gottesdiener hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3: Includes 303 shares acquired under the issuer's 2017 Employee Stock Purchase Plan on February 28, 2019.

F4: On March 14, 2019, Mr. Gottesdiener sold 1,506 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F5: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.50, inclusive; the price reported above reflects the weighted average sale price. Mr. Gottesdiener hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.